Table 2 summarizes the extensive research on the impact of the antioxidant resveratrol on assisted reproductive outcomes in various species. Through a study of 61 patients with PCOS, Bahramrezaie found that oral administration of 40 mg/day resveratrol to PCOS patients undergoing ICSI increased the rate of high-quality oocytes and high-quality embryos. This may function through altering serum levels of sex hormones and the expression of VEGF and HIF1 genes in granulosa cell angiogenesis pathways [68]. This evidence concerns the gene VEGFA and polycystic ovary syndrome.